Cordis Corp.
J&J deals Cordis to Cardinal Health for nearly $2B
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Report: Cardinal Health top suitor for J&J’s Cordis unit
Healthcare giant Johnson & Johnson (NYSE:JNJ) may have found a buyer for its Cordis business, according to Bloomberg News.
Manufacturers, medical societies team up for IVC filter study
Cordis brings Incraft AAA stent graft to Europe and Canada
Johnson & Johnson (NYSE:JNJ) subsidiary Cordis is taking its Incraft AAA stent abroad after winning regulatory approvals to market the device in Europe and Canada.
Press Release: Cordis Corporation launches INCRAFT AAA stent graft system for treatment of abdominal aortic aneurysms
Covidien acquires Sapheon and its VenaSeal device | The week in medtech M&A
Covidien acquires Sapheon and its VenaSeal varicose vein treatment
August 28, 2014 by Brad Perriello
Report: J&J puts Cordis on the block
Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company’s stents, catheters and other vascular devices, according to a report from the Wall Street Journal.